Terfluranol

Terfluranol (INN, BAN) (developmental code name BX-428) is a synthetic, nonsteroidal estrogen of the stilbestrol group related to diethylstilbestrol that was developed for the treatment of breast cancer but was never marketed.[1][2] It was described in the medical literature in 1974.[1]

Terfluranol
Clinical data
ATC code
  • None
Identifiers
  • 4-[(2R,3S)-5,5,5-trifluoro-3-(4-hydroxyphenyl)pentan-2-yl]phenol
CAS Number
PubChem CID
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC17H17F3O2
Molar mass310.316 g·mol−1
3D model (JSmol)
  • CC(C1=CC=C(C=C1)O)C(CC(F)(F)F)C2=CC=C(C=C2)O
  • InChI=1S/C17H17F3O2/c1-11(12-2-6-14(21)7-3-12)16(10-17(18,19)20)13-4-8-15(22)9-5-13/h2-9,11,16,21-22H,10H2,1H3/t11-,16-/m0/s1
  • Key:KTUJPJJUMKZGCV-ZBEGNZNMSA-N

See also

References
  1. Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. p. 1161. ISBN 978-1-4757-2085-3.
  2. Polska Akademia Nauk. Komitet Badania Polonii (1984). II Kongres Uczonych Polskiego Pochodzenia: zbiór materiałów. Zakład Narodowy im. Ossolińskich. p. 451. ISBN 978-83-04-01670-5.


This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.